Cleared Traditional

SuperNO2VA Et Device (K173147) - FDA 510(k) Clearance

Class II Anesthesiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2018
Decision
264d
Days
Class 2
Risk

K173147 is an FDA 510(k) clearance for the SuperNO2VA Et Device. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Revolutionary Medical Devices, Inc. (Tucson, US). The FDA issued a Cleared decision on June 20, 2018 after a review of 264 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Revolutionary Medical Devices, Inc. devices

Submission Details

510(k) Number K173147 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 29, 2017
Decision Date June 20, 2018
Days to Decision 264 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
124d slower than avg
Panel avg: 140d · This submission: 264d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Consultant

ProMedic, LLC
Paul Dryden

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 61
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K173147.
CO2 Sampling Line
K181981 · Tylenol Medical Instruments Co., Ltd. · Feb 2019
MediPines Gas Exchange Monitor (GEM), Accessory Mouthpiece Disposable Assembly
K180902 · Medipines Corporation · Jan 2019
Capnograph and Oximeter
K170820 · Cmi Health, Inc. · Jul 2018
ETCO2 Sensor
K171828 · Orantech, Inc. · May 2018
Gas Sampling Line, Coextruded, 2m/7ft, 10/pkg, Disposable/ 100/pkg, Disposable, Gas Sampling Line, Coextruded, 2.5m/8ft, 10/pkg, Disposable, Gas Sampling Line, Coextruded, 3m/10ft, 10/pkg, Disposable/ 100/pkg, Disposable, Gas Sampling Line, Coextruded, 6m/20ft, 5/pkg, Disposable
K171678 · Vyaire Medical, Inc. · Apr 2018
Panoramic Oxygen Mask (POM)
K172365 · Pom Medical, LLC · Apr 2018